Seres Therapeutics Inc.
MCRB
|
|
| |
|
| Trading Volume | 5,922 |
|
|
3.63 - 0.58 |
| Market Cap Full | $ 103.4M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 7.2% | -44.4% | 1.3% | -14.5% |
| Q2 | - | 1.4% | -15.5% | -51.8% |
| Q3 | - | -40.7% | -50.3% | 87.2% |
| Q4 | - | 17.2% | -34.9% | -12.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -19.3 | 0.9 | -31.8 | -25.1 | 73.2 | -22.9 | 73.3 | -40.7 | - | - | - | -14.6 |
| 2023 | |||||||||||
| -2.3 | -7.7 | 12.3 | -14 | 1.5 | -3.2 | 0.4 | -28.3 | -31 | -35.7 | -32 | 34.6 |
| 2022 | |||||||||||
| 0.1 | -2.8 | -12.2 | -33.6 | -31.9 | 6.5 | 19.7 | 25.2 | 24.9 | 38 | -26.6 | -13.9 |
| 2021 | |||||||||||
| -4.9 | -18.3 | 8.1 | 1.1 | 2.3 | 12 | -70.2 | -9.7 | 8.6 | -11.6 | 75 | -22.6 |
| 2020 | |||||||||||
| -10.9 | 3.9 | 9.5 | 3.1 | 49.2 | -13.3 | -21.4 | 608.3 | 6.9 | -3.4 | 0.9 | -11.3 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.6 | -0.6 | -0.4 | -0.3 |
| Q2 | 0.4 | -0.7 | -0.5 | -0.3 |
| Q3 | -0.4 | -0.5 | 0.7 | -0.4 |
| Q4 | 0 | -0.5 | -0.5 | -0.2 |
| A | -0.58 | -2.3 | -0.7 | -1.1 |